Find comprehensive information on opiate dependence diagnosis, including clinical documentation, medical coding (ICD-10 F11.20, DSM-5 304.00), opioid use disorder treatment, withdrawal management, and best practices for healthcare professionals. Learn about opiate addiction symptoms, screening tools, and resources for patients and clinicians. Explore accurate and up-to-date guidance on opiate dependence diagnosis coding and documentation for optimal patient care and billing.
Also known as
Opioid-related disorders
Covers opioid dependence, abuse, and intoxication.
Unspecified opioid-related disorder
Used when a more specific opioid disorder is not identified.
Contact with and suspected exposure to other drugs
May be used for patients with past opioid dependence currently in remission.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the opiate dependence confirmed?
When to use each related code
| Description |
|---|
| Opiate dependence, tolerance and withdrawal. |
| Opioid Use Disorder, mild. |
| Opioid Induced Mood Disorder |
Coding opiate dependence without specifying the drug leads to inaccurate data and potential underpayment. Use specific opiate codes when documented.
Failing to document and code the remission status (early, sustained, etc.) affects severity and resource utilization, impacting reimbursement.
Overlooking mental health or other substance use disorders accompanying opiate dependence leads to inaccurate risk adjustment and lower reimbursement.
Patient presents with opiate dependence, fulfilling DSM-5 criteria for opioid use disorder. The patient reports a chronic pattern of opioid use, characterized by escalating doses and unsuccessful attempts to quit. Symptoms include opioid cravings, tolerance to opioids, withdrawal symptoms upon cessation or dose reduction, and continued use despite negative consequences such as relationship problems, financial difficulties, and health issues. The patient acknowledges a loss of control over opioid use and spends a significant amount of time obtaining, using, or recovering from the effects of opioids. Physical examination may reveal signs of opioid intoxication or withdrawal including pupillary constriction or dilation, sweating, tremors, nausea, vomiting, and changes in heart rate and blood pressure. Laboratory testing may be conducted to assess for opioid levels and screen for co-occurring medical conditions such as hepatitis C or HIV. Assessment includes evaluation of opioid withdrawal severity using the Clinical Opiate Withdrawal Scale (COWS) and assessment of psychosocial factors contributing to opioid dependence. Diagnosis of opiate dependence is supported by patient history, clinical presentation, and laboratory findings. The treatment plan includes opioid detoxification with medically assisted treatment (MAT) using medications such as buprenorphine or methadone, combined with individual and group therapy addressing underlying psychological issues and relapse prevention strategies. Patient education regarding opioid overdose prevention and naloxone administration will be provided. Referral to community support services will be facilitated for ongoing recovery support and case management. Prognosis depends on patient motivation, adherence to treatment, and the presence of co-occurring mental health disorders. Follow-up appointments will be scheduled to monitor treatment progress, manage withdrawal symptoms, and address any relapse concerns. Medical coding will utilize ICD-10-CM code F11.20 for opiate dependence.